• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM S.R.L. PERCEVAL PLUS SUTRUELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM S.R.L. PERCEVAL PLUS SUTRUELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVF-S
Medical Device Problem Code Patient-Device Incompatibility (2682)
Health Effect - Clinical Code Heart Block (4444)
Date of Event 12/20/2022
Type of Reportable Event Serious Injury
Event or Problem Description
The manufacturer was informed of the following event through received mantra study database.Based on the information received, on 12 dec 2022, small perceval plus valve was implanted in the patient.The surgical approach was mini thoracotomy and there was no concomitant procedure performed.The site reported asystole on (b)(6) 2022 which led to 12 seconds of cardiac massage.Furthermore, a conduction disturbance that started on (b)(6) 2022 was also reported which required a temporary pacemaker to be inserted.Based on the information received, a permanent pacemaker was eventually implanted on (b)(6) 2022 to address the complete av block.The outcome was indicated as recovered/resolved.Based on the information available in the database, patient had a history of arrhythmia (sinus arrhythmia), cardiac conduction disorder, stroke, and peripheral vascular disease (carotid artery disease).
 
Additional Manufacturer Narrative
A complete manufacturing and material records review for the device has been performed.The results confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.Based on the available information, it is not possible to draw a definitive root cause on the reported event.However, based on the document review performed, no manufacturing deficiencies were identified.Conduction disorders are common in patients with aortic valve diseases.As a result, it is common for patients to receive permanent pacemaker implantation after aortic valve replacement.Risk factors include preexisting conducting disease and preoperative aortic regurgitation.This event is, therefore, a known, inherent risk of the procedure, and it is listed among the potential adverse events in the perceval plus ifu.Device remained implanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL PLUS SUTRUELESS AORTIC HEART VALVE
Common Device Name
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM S.R.L.
strada crescentino
saluggia, vercelli 13040
IT  13040
Manufacturer (Section G)
CORCYM S.R.L.
strada crescentino
saluggia, vercelli 13040
IT   13040
Manufacturer Contact
laura mannino
5005 north fraser way
burnaby, bc V5J 5-M1
CA   V5J 5M1
MDR Report Key16244687
Report Number3005687633-2023-00097
Device Sequence Number12400190
Product Code LWR
UDI-Device Identifier08022057015365
UDI-Public(01)08022057015365(240)PVF-S(17)260914
Combination Product (Y/N)N
Initial Reporter CountryKS
PMA/510(K) Number
P15011/S013
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 01/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/14/2026
Device Model NumberPVF-S
Device Catalogue NumberPVF-S
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/27/2022
Initial Report FDA Received Date01/25/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured09/15/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age67 YR
Patient SexFemale
-
-